Small Cap Shares Moleculin Biotech Inc. MBRX, + 3.77% A 43% surge in pre-market trade Tuesday, after the company said a second round of laboratory tests confirmed antiviral activity for WP1122, its candidate for treatment for COVID-19. The laboratory involved was the IIT Research Institute, an affiliate of the Illinois …
Read More »Moleculin Biotech says a second lab test found antiviral activity for possible COVID-19 treatment
